Which position will the nurse use when caring for a patient who is experiencing an asthma exacerbation prone supine high Fowlers Trendelenburg?

1. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832–836. doi: 10.1016/j.jaci.2003.12.591. [PubMed] [CrossRef] [Google Scholar]

2. Ring J, Grosber M, Mührenschlager M, Brockow K. Anaphylaxis: acute treatment and management. Chem Immunol Allergy. 2010;95:201–10. doi: 10.1159/000315953. [PubMed] [CrossRef] [Google Scholar]

3. Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2011;127:587–593. doi: 10.1016/j.jaci.2011.01.038. [PubMed] [CrossRef] [Google Scholar]

4. Tryba M, Ahnefeld F, Barth J, Dick W, Doenicke A, Fuchs T, et al. Akuttherapie anaphylaktoider Reaktionen. Ergebnisse einer interdisziplinären Konsensuskonferenz. Allergo J. 1994;3:211–222. [PubMed] [Google Scholar]

5. Ring J, Brockow K, Duda D, Eschenhagen T, Fuchs T, Huttegger I, et al. Emergency treatment of anaphylactic reactions. Allergo J. 2007;16:420–434. [Google Scholar]

6. Bresser H, Sander CH, Rakoski J. Emergencies by insect stings in Munich in 1992. Allergo J. 1995;4:373–376. [Google Scholar]

7. Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children — a questionnaire-based survey in Germany. Allergy. 2005;60:1440–1445. doi: 10.1111/j.1398-9995.2005.00909.x. [PubMed] [CrossRef] [Google Scholar]

8. Portier P, Richet C. De l’action anaphylactique de certains venins. C R Soc Biol. 1902;54:170. [Google Scholar]

9. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report — Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391–397. doi: 10.1016/j.jaci.2005.12.1303. [PubMed] [CrossRef] [Google Scholar]

10. Worm M. Epidemiology of anaphylaxis. Chem Immunol Allergy. 2010;95:12–21. doi: 10.1159/000315935. [PubMed] [CrossRef] [Google Scholar]

11. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005;60:443–451. doi: 10.1111/j.1398-9995.2005.00785.x. [PubMed] [CrossRef] [Google Scholar]

12. Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy. 2004;34:285–290. doi: 10.1111/j.1365-2222.2004.01882.x. [PubMed] [CrossRef] [Google Scholar]

13. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. 2008;122:1161–1165. doi: 10.1016/j.jaci.2008.09.043. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

14. Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med. 2008;101:139–143. doi: 10.1258/jrsm.2008.070306. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

15. Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993–1994 to 2004–2005. J Allergy Clin Immunol. 2007;120:878–884. doi: 10.1016/j.jaci.2007.07.040. [PubMed] [CrossRef] [Google Scholar]

16. Worm M, Edenharter G, Rueff F, Scherer K, Pföhler C, Mahler V, et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy. 2012;67:691–698. doi: 10.1111/j.1398-9995.2012.02795.x. [PubMed] [CrossRef] [Google Scholar]

17. Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest. 1980;66:1072–1080. doi: 10.1172/JCI109936. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

18. Vadas P, Perelman B, Liss G. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. J Allergy Clin Immunol. 2013;131:144–149. doi: 10.1016/j.jaci.2012.08.016. [PubMed] [CrossRef] [Google Scholar]

19. Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin Exp Allergy. 2011;41:923–938. doi: 10.1111/j.1365-2222.2011.03779.x. [PubMed] [CrossRef] [Google Scholar]

20. Ring J. Angewandte Allergologie. München: Urban & Vogel; 2004. [Google Scholar]

21. Rueff F, Przybilla B, Bilo MB, Müller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124:1047–1054. doi: 10.1016/j.jaci.2009.08.027. [PubMed] [CrossRef] [Google Scholar]

22. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226–232. doi: 10.1111/j.1398-9995.2007.01569.x. [PubMed] [CrossRef] [Google Scholar]

23. Guenova E, Volz T, Eichner M, Hoetzenecker W, Caroli U, Griesinger G, et al. Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly. Allergy. 2010;65:919–923. doi: 10.1111/j.1398-9995.2009.02302.x. [PubMed] [CrossRef] [Google Scholar]

24. Przybilla B, Ruëff F, Walker B, Räwer HC, Aberer W, Bauer CP, et al. Diagnosis and therapy of bee and wasp venom allergy. Allergo J. 2011;20:318–339. [Google Scholar]

25. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy. 2007;62:857–871. doi: 10.1111/j.1398-9995.2007.01421.x. [PubMed] [CrossRef] [Google Scholar]

26. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466–469. doi: 10.1016/S0140-6736(77)91953-5. [PubMed] [CrossRef] [Google Scholar]

27. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986;78:76–83. doi: 10.1016/0091-6749(86)90117-X. [PubMed] [CrossRef] [Google Scholar]

28. Commins SP, Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol. 2009;124:652–657. doi: 10.1016/j.jaci.2009.08.026. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

29. Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol. 1973;52:259–264. doi: 10.1016/0091-6749(73)90044-4. [PubMed] [CrossRef] [Google Scholar]

30. Delage C, Irey NS. Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forensic Sci. 1972;17:525–540. [PubMed] [Google Scholar]

31. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care. 1986;14:17–21. [PubMed] [Google Scholar]

32. Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. 2000;53:273–276. doi: 10.1136/jcp.53.4.273. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

33. von Krogh G, Maibach HI. The contact urticaria syndrome — an updated review. J Am Acad Dermatol. 1981;5:328–342. doi: 10.1016/S0190-9622(81)70099-9. [PubMed] [CrossRef] [Google Scholar]

34. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol. 2002;110:341–348. doi: 10.1067/mai.2002.126811. [PubMed] [CrossRef] [Google Scholar]

35. Morita E, Kunie K, Matsuo H. Food-dependent exercise-induced anaphylaxis. J Dermatol Sci. 2007;47:109–117. doi: 10.1016/j.jdermsci.2007.03.004. [PubMed] [CrossRef] [Google Scholar]

36. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30:1144–1150. doi: 10.1046/j.1365-2222.2000.00864.x. [PubMed] [CrossRef] [Google Scholar]

37. Mullins RJ, Dear KB, Tang ML. Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007. J Allergy Clin Immunol. 2009;123:689–693. doi: 10.1016/j.jaci.2008.12.1116. [PubMed] [CrossRef] [Google Scholar]

38. Schwartz LB. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk Res. 2001;25:553–562. doi: 10.1016/S0145-2126(01)00020-0. [PubMed] [CrossRef] [Google Scholar]

39. Brockow K, Vieluf D, Püschel K, Grosch J, Ring J. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol. 1999;104:237–238. doi: 10.1016/S0091-6749(99)70141-7. [PubMed] [CrossRef] [Google Scholar]

40. Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation. 2010;81:1219–1276. doi: 10.1016/j.resuscitation.2010.08.021. [PubMed] [CrossRef] [Google Scholar]

41. Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J. 2005;22:272–273. doi: 10.1136/emj.2005.023507. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

42. Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol. 2012;130:597–606. doi: 10.1016/j.jaci.2012.06.035. [PubMed] [CrossRef] [Google Scholar]

43. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356:2139–2143. doi: 10.1016/S0140-6736(00)03495-4. [PubMed] [CrossRef] [Google Scholar]

44. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med. 2005;142:510–524. doi: 10.7326/0003-4819-142-7-200504050-00010. [PubMed] [CrossRef] [Google Scholar]

45. Gronemeyer. Noradrenalin statt Adrenalin beim anaphylaktischen Schock. Dtsch Med Wochenschr. 1980;102:101. [PubMed] [Google Scholar]

46. Hoffmann BB. Catecholamines, sympathomimetic drugs and adrenergic receptor anatagonists. In: Hardman JG, Limbird LE, Goodman A, editors. Goodman & Gilman’s. The pharmaceutical basis of therapeutics. NewYork: Mc Graw Hill; 2002. [Google Scholar]

47. Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg. 2008;107:620–624. doi: 10.1213/ane.0b013e3181770b42. [PubMed] [CrossRef] [Google Scholar]

48. Meßmer K. Plasma substitutes and indications for their use. In: Tinker J, Rapin M, editors. Care of the critically ill patient. Berlin — Heidelberg — New York: Springer; 1983. pp. 569–575. [Google Scholar]

49. Stölting RK. Systemic circulation. Pharmacology & physiology in anesthetic practice. Philadelphia: J.B. Lippincott Company; 2006. pp. 661–678. [Google Scholar]

50. Walther A, Böttiger BW. Anaphylaktoide Reaktionen in der Prähospitalphase. Internist. 2004;45:296–304. doi: 10.1007/s00108-003-1142-y. [PubMed] [CrossRef] [Google Scholar]

51. Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726–1734. doi: 10.1056/NEJMra1208943. [PubMed] [CrossRef] [Google Scholar]

52. Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology. 2013;118:387–394. doi: 10.1097/ALN.0b013e31827e5569. [PubMed] [CrossRef] [Google Scholar]

53. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–1911. doi: 10.1056/NEJMoa1209759. [PubMed] [CrossRef] [Google Scholar]

54. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007;62:830–837. doi: 10.1111/j.1398-9995.2007.01435.x. [PubMed] [CrossRef] [Google Scholar]

55. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK. Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427–1443. doi: 10.1111/j.1398-9995.2009.02178.x. [PubMed] [CrossRef] [Google Scholar]

56. Pragst F, Herre S, Bakdash A. Poisonings with diphenhydramine — a survey of 68 clinical and 55 death cases. Forensic Sci Int. 2006;161:189–197. doi: 10.1016/j.forsciint.2006.01.019. [PubMed] [CrossRef] [Google Scholar]

57. Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L, et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med. 2000;36:462–468. doi: 10.1016/S0196-0644(00)43749-2. [PubMed] [CrossRef] [Google Scholar]

58. Ring J, Rothenberger KH, Clauss W. Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial. Int Arch Allergy Appl Immunol. 1985;78:9–14. doi: 10.1159/000233854. [PubMed] [CrossRef] [Google Scholar]

59. Brockow K, Kiehn M, Riethmüller C, Vieluf D, Berger J, Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1997;100:458–463. doi: 10.1016/S0091-6749(97)70135-0. [PubMed] [CrossRef] [Google Scholar]

60. Aouam K, Bouida W, Ben Fredj N, Chaabane A, Boubaker H, Boukef R, et al. Severe ranitidine-induced anaphylaxis: a case report and literature review. J Clin Pharm Ther. 2012;37:494–496. doi: 10.1111/j.1365-2710.2011.01320.x. [PubMed] [CrossRef] [Google Scholar]

61. Winbery SL, Lieberman PL. Histamine and antihistamines in anaphylaxis. Clin Allergy Immunol. 2002;17:287–317. [PubMed] [Google Scholar]

62. Choo KJ, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2010;65:1205–1211. doi: 10.1111/j.1398-9995.2010.02424.x. [PubMed] [CrossRef] [Google Scholar]

63. Fischer J, Biedermann T. Anaphylaxis due to allergological testing or therapy — a compact compendium for emergency management. Allergo J. 2009;18:124–131. [Google Scholar]

64. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie Asthma — Langfassung, 2. Aufl. Version 5. 2009, zuletzt geändert: August 2013 [cited: 26.02.2014]; http://www.versorgungsleitlinien.de/themen/asthma

65. Hartmann K, Biedermann T, Brockow K, Grabbe J, Horny H-P, Lippert U, et al. Mastocytosis. Guideline of the German Society for Allergology an Clinical Immunology (DGAKI) and the German Society for Dermatology (DDG) Allergo J. 2009;18:196–207. [Google Scholar]

66. Simons FE, Ardusso LR, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF, et al. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol. 2013;162:193–204. doi: 10.1159/000354543. [PubMed] [CrossRef] [Google Scholar]

67. Lieberman JA, Chehade M. Use of omalizumab in the treatment of food allergy and anaphylaxis. Curr Allergy Asthma Rep. 2013;13:78–84. doi: 10.1007/s11882-012-0316-x. [PubMed] [CrossRef] [Google Scholar]

68. Ring J, Beyer K, Dorsch A, Biedermann T, Fischer J, Friedrichs F, et al. Anaphylaxis school — a new educational program for tertiary prevention in patients with anaphylaxis. Allergo J. 2012;21:96–102. doi: 10.1007/s15007-012-0044-5. [CrossRef] [Google Scholar]

69. Fischer J, Kupfer J, Grosber M, Friedl T, Schallmeyer S, Rueff F, et al. Practical skills in the self therapy of anaphylaxis — development and evaluation of a test on decision making and prctical performance. Allergo J. 2013;22:18–24. doi: 10.1007/s15007-013-0014-6. [CrossRef] [Google Scholar]

Page 2

Allergo Journal International